Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.

about

C3a triggers formation of sub-retinal pigment epithelium deposits via the ubiquitin proteasome pathway.Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease.

P2860

Q55426544-8678BA55-40BA-4433-A97A-DCCAFDD35F28 Q55710477-18FD46E7-E715-488F-877A-889A5CB3613E

P2860

Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.

Item

http://www.wikidata.org/entity/Q49223224

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@en

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@nl

type

Item

label

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@en

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@nl

prefLabel

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@en

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@nl

P1476

Effect of Anti-C5a Therapy in ...... -Related Macular Degeneration.

@en

P2093

Catherine Bowes Rickman

http://www.w3.org/2001/XMLSchema#string

Christopher B Toomey

http://www.w3.org/2001/XMLSchema#string

Daniel R Saban

http://www.w3.org/2001/XMLSchema#string

Holly Dong

http://www.w3.org/2001/XMLSchema#string

John C Lin

http://www.w3.org/2001/XMLSchema#string

John Deans

http://www.w3.org/2001/XMLSchema#string

Michael Landowski

http://www.w3.org/2001/XMLSchema#string

Ons Harrabi

http://www.w3.org/2001/XMLSchema#string

Ruslan Grishanin

http://www.w3.org/2001/XMLSchema#string

Thomas Van Blarcom

http://www.w3.org/2001/XMLSchema#string

P2860

An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice

Drusen complement components C3a and C5a promote choroidal neovascularization

Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes

Function, structure and therapeutic potential of complement C5a receptors

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

AMD and the alternative complement pathway: genetics and functional implications

Animal models of age related macular degeneration

An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration

Complement System Part II: Role in Immunity

Systemic complement activation in age-related macular degeneration

P304

662-673

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.17-23134

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mikael Klingeborn

P577

2018-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29392311

http://www.w3.org/2001/XMLSchema#string

P932

5795897

http://www.w3.org/2001/XMLSchema#string

Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.

about

P2860

P2860

Effect of Anti-C5a Therapy in a Murine Model of Early/Intermediate Dry Age-Related Macular Degeneration.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932